Dudediligence.

Quince Therapeutics, Inc

QNCXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Oct 28-KOfficer or director change5.02
  2. Sep 148-KAcquisition or sale of assets completed and officer or director change2.015.029.01
  3. Sep 48-KListing notice or transfer3.01
  4. Aug 278-KOfficer or director change5.02
  5. Aug 178-KOther events8.019.01
  6. Aug 1513GPassive stake of 5% or more (13G), filed by Ikarian Capital
  7. Aug 1410-QQuarterly report
  8. Aug 1413GPassive stake of 5% or more (13G), filed by Cormorant Asset Management
  9. Aug 148-KResults of operations2.029.01
  10. Aug 1413GPassive stake of 5% or more (13G), filed by Balyasny Asset Management
  11. Aug 413GPassive stake of 5% or more (13G), filed by Squadron Capital Management
  12. Jul 318-KOfficer or director change5.02
  13. Jul 31S-3Shelf registration
  14. Jul 308-K/AOther events (amended)8.019.01
  15. Jun 268-K/AChange to shareholder rights (amended)3.03
  16. Jun 268-KBylaws or fiscal year changed and change to shareholder rights3.035.039.01
  17. Jun 118-KShareholder vote5.07
  18. May 218-KOther events8.01
  19. May 188-K/ARegulation FD disclosure (amended)7.019.01
  20. May 188-KMaterial agreement and acquisition or sale of assets completed1.012.013.025.025.037.019.01
  21. May 1110-QQuarterly report
  22. Apr 288-KOther events8.01
  23. Apr 228-KOfficer or director change5.02
  24. Apr 1010-KAnnual report
  25. Apr 98-KBylaws or fiscal year changed and change to shareholder rights3.035.039.01
  26. Mar 308-KRegulation FD disclosure and end of a material agreement1.027.019.01
  27. Mar 208-KListing notice or transfer3.01
  28. Feb 128-KResults of operations and other events2.028.01
  29. Feb 28-KOfficer or director change5.02
  30. Jan 298-KOther events8.019.01
  31. Nov 12, 202510-QQuarterly report
  32. Nov 12, 20258-KResults of operations2.029.01
  33. Oct 17, 20258-KRegulation FD disclosure7.01
  34. Oct 17, 2025424B5Prospectus for an offering
  35. Sep 26, 20258-KMaterial agreement and new debt or obligation1.012.03
  36. Aug 11, 202510-QQuarterly report
  37. Aug 11, 20258-KResults of operations2.029.01
  38. Aug 5, 2025424B5Prospectus for an offering
  39. Jul 25, 2025S-3Shelf registration
  40. Jul 16, 20258-KRegulation FD disclosure and other events7.018.019.01
  41. Jun 13, 20258-KMaterial agreement and unregistered sale of shares1.013.029.01
  42. Jun 5, 20258-KShareholder vote5.07
  43. May 13, 202510-QQuarterly report
  44. May 13, 20258-KResults of operations2.029.01
  45. Mar 24, 2025424B5Prospectus for an offering
  46. Mar 24, 202510-KAnnual report
  47. Mar 24, 20258-KResults of operations2.029.01
  48. Dec 27, 2024424B5Prospectus for an offering
  49. Dec 18, 2024S-3Shelf registration
  50. Nov 14, 20248-KOther events8.01
  51. Nov 13, 202410-QQuarterly report
  52. Nov 13, 20248-KResults of operations2.029.01